CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation (Q38983710)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation |
scientific article |
Statements
1 reference
CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation (English)
1 reference
Fumihiro Tanaka
Yoshitaka Sekido
Hiroshi Mizuuchi
Toshiki Takemoto
Isao Murakami
Katsuaki Sato
2 June 2014
1 reference
1 reference